Edinburgh based 1nhaler announced GBP 2.2 million in follow on funding on 3 November 2026. Archangels led the round with support from Scottish Enterprise and BBB Investments. Founders Don Smith and Lisa McMyn are developing a single dose dry powder inhaler made predominantly from cardboard. The device stores flat like a credit card and opens into a usable inhaler. The financing will support manufacturing transfer, clinical material production and a small study for the company’s salbutamol product. 1nhaler is targeting a regulatory filing in late 2027 and will also study commercial scale manufacturing with equipment specialist Harro Höfliger.
1nhaler secures GBP 2.2m follow on
Archangels leads development funding for cardboard inhaler

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


